NovoCure (NVCR) Non-Current Debt (2015 - 2026)

NovoCure (NVCR) has reported Non-Current Debt for 12 consecutive years, with $195.9 million the latest figure, recorded in Q2 2026.

• Quarterly Non-Current Debt rose 100.69% year-over-year to $195.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $195.9 million (up 100.69% YoY) and the FY2025 annual result came in at $195.0 million, up 100.46% from the prior year.
• Non-Current Debt held at $195.9 million in Q2 2026 per NVCR's latest filing, from $195.5 million in the prior quarter.
• Over the last five years, Non-Current Debt for NVCR reached as high as $569.7 million in Q1 2024 and fell as low as $97.0 million in Q2 2024.
• A 5-year average of $340.9 million and a median of $195.9 million in 2026 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2024 — Non-Current Debt slumped 82.9% — and 2026, when it soared 100.69%.
• Year by year, Non-Current Debt stood at $565.5 million in 2022, then rose by 0.44% to $568.0 million in 2023, then plunged by 82.87% to $97.3 million in 2024, then soared by 100.46% to $195.0 million in 2025, then advanced by 0.43% to $195.9 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $195.9 million, $195.5 million, and $195.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.